Loading clinical trials...
Loading clinical trials...
The purpose of this study is to identify 1 or more doses of daclatasvir, which when used in combination with pegylated interferon alpha and ribavirin, are safe and demonstrate sufficient anti-hepatiti...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT01866930 · Chronic Hepatitis C Infection
NCT02190305 · HIV Infections, Hepatitis B Infections, and more
NCT02333292 · Chronic Hepatitis C Infection
NCT00991289 · HIV Infection, Hepatitis C Infection
NCT02582632 · Hepatitis C Infection, Hepatitis C Virus
Alabama Liver & Digestive Specialists (Alds)
Montgomery, Alabama
University Of Colorado Denver & Hospital
Aurora, Colorado
Yale University School Of Medicine
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions